Steve C. Glover

Filings by Steve C. Glover span 3 companies, the busiest being INSMED Inc, PDS Biotechnology Corp and Auriga Laboratories, Inc. We count 13 filings; the first trade dates from 10 December 2006 and the latest from 15 June 2021.

No open-market sale appears; the market trades are 6 purchases worth €88k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants and 1 option exercise. Since January 2021: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €5,584.

Most recently, on 17 June 2021, the filings show an open-market purchase worth €41k in PDS Biotechnology Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.